会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 7. 发明授权
    • Heterocyclic compounds useful as Nurr-1 activators
    • 用作Nurr-1激活剂的杂环化合物
    • US07432293B2
    • 2008-10-07
    • US10545245
    • 2004-02-13
    • Samuel HintermannBastian HengererBoris Schmidt
    • Samuel HintermannBastian HengererBoris Schmidt
    • A61K31/42A61K31/4245C07D263/30C07D271/06
    • C07D271/06C07D261/08C07D263/32C07D413/04
    • The present invention relates to compounds of formula (I): wherein R1 is hydroxy, C1-4 alkoxy, amino, C1-4 alkyl-amino, di C1-4alkylamino, benzyloxy or C2-C7 alkanoyl, R2 is C1-4 alkyl, C1-4 alkoxy, C1-4 alkoxy C1-4alkoxy, CF3, halogen, C1-4alkylamino, di C1-4alkylamino, di C1-4 alkylamino C1-4 alkoxy or N—C1-4 alkoxy C1-4 alkyl-N—C1-4 alkylamino, N—C1-4 alkyl-piperazinyl, morpholinyl or pyrrolidinyl-C1-4 alkoxy, wherein the C1-4 alkyl radicals in R2 are optionally further substituted by C1-4 alkyl, halogen, cyano, amino, alkoxy or alkylthio, X is N or O, Y is N, O or CH, Z is N or CH, and W is N or CH, provided that (a) R1 is not hydroxy or C1-4 alkoxy when R2 is CF3, X is O, Y is CH, Z is N and W is CH, (b) R1 is not hydroxy or C1-4 alkoxy when R2 is CF3 or chloro, X is N, Y is O, Z is CH and W is CH, (c) R1 is not hydroxy when R2 is CF3, X is O, Y is N, Z is CH and W is CH and (d) X and Y are not simultaneously O, the salts thereof; their preparation, their use and pharmaceutical compositions containing them.
    • 本发明涉及式(I)的化合物:其中R 1是羟基,C 1-4烷氧基,氨基,C 1-4 烷基 - 氨基,二C 1-4烷基氨基,苄氧基或C 2 -C 7烷酰基,R 2 为C 1-4烷基,C 1-4烷氧基,C 1-4烷氧基C 1-4烷基 烷氧基,CF 3,卤素,C 1-4烷基氨基,二C 1-4烷基氨基,二C 1-4 烷基氨基C 1-4烷氧基或NC 1-4烷氧基C 1-4烷基-NC 1-4 烷基氨基,NC 1-4烷基 - 哌嗪基,吗啉基或吡咯烷基-C 1-4烷氧基,其中C 1-4 - R 2中的烷基任选进一步被C 1-4烷基,卤素,氰基,氨基,烷氧基或烷硫基取代,X是N或O,Y是N ,O或CH,Z是N或CH,W是N或CH,条件是当R(R)不为羟基或C 1-4烷氧基时, 2是CF 3,X是O,Y是C H,Z是N,W是CH,(b)当R 2是CF时,R 1不是羟基或C 1-4烷氧基 3是或氯,X是N,Y是O,Z是CH,W是CH,(c)R 1不是羟基, SUB>是CF 3,X是O,Y是N,Z是CH,W是CH,(d)X和Y不同时为O,其盐; 它们的制备,它们的用途和含有它们的药物组合物。